Healthcare stocks were flat to higher premarket Tuesday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.8%.

Johnson & Johnson (JNJ) stock was down more than 2% after the company reported lower fiscal Q3 adjusted earnings, while revenue increased during the period.

UnitedHealth Group (UNH) shares were up more than 4% after the company posted higher Q3 adjusted earnings and raised its 2026 adjusted EPS outlook.

BioNTech's (BNTX) phase 2/3 trial of BNT113, combined with pembrolizumab, in head and neck cancer failed to meet one of its two primary endpoints, the company said. Shares of BioNTech were down more than 4% pre-bell.